The Third Edition of Handbook of Evidence-Based Radiation Oncology updates and revises the previous successful editions and serves as a key reference for radiation oncology professionals. Organized by body site, concise clinical chapters provide easy access to critical information. Important "pearls" of epidemiology, anatomy, pathology, and clinical presentation are highlighted. The key elements of the work-up are listed, followed by staging and/or risk classification systems. Treatment recommendations are discussed based on stage, histology, and/or risk classification. Brief summaries of key trials and studies provide the rationale for the recommendations. Practical guidelines for radiation techniques are described and complications and follow-up guidelines are outlined. The Third Edition incorporates new key studies and trials to reflect current radiation oncology practice; includes the most recent staging systems; and features new color illustrations and anatomic atlases to aid in treatment planning. This book is a valuable resource for students, resident physicians, fellows, and other practitioners of radiation oncology. 

Eric K. Hansen, MD

The Oregon Clinic

Radiation Oncology

Providence St. Vincent Medical Center

Portland, OR, USA

Mack Roach III MD, FACR, FASTRO

Professor

Radiation Oncology and Urology

Director

Particle Therapy Research Program& Outreach

Department of Radiation Oncology

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, CA, USA

Eric Hansen is a Board Certified Radiation Oncologist. He graduated with honors from Yale University (BA) and Oregon Health& Science University (MD). He completed his radiation oncology residency at University of California San Francisco. Dr. Hansen served as President of the Oregon Radiation Oncology Society and is a member of the American Society of Radiation Oncology.

Mack Roach III, MD, is a Professor of Radiation Oncology, Medical Oncology and Urology, at the University of California, San Francisco. Roach earned his MD from Stanford University School of Medicine. His major research interest involves the application of 3-D conformal and intensity modulated radiotherapy (IMRT) treatment planning technology as a major component of combined modality management of prostate cancer and other solid tumors.

Skin Cancer.- Central Nervous System.- Malignant and Benign Diseases of the Eye and Orbit.- Cancer of the Ear.- Nasopharyngeal Cancer.- Nasal Cavity and Paranasal Sinus Cancer.- Oropharyngeal Cancer.- Cancer of the Lip and Oral Cavity.- Larynx and Hypopharynx Cancer.- Salivary Gland Tumors.- Thyroid Cancer.- Unusual Neoplasms of the Head and Neck.- Management of the Neck and Unknown Primary of the Head and Neck.- Small Cell Lung Cancer.- Non-small Cell Lung Cancer.- Mesothelioma and Thymic Tumors.- Breast Cancer.- Esophageal Cancer.- Gastric Cancer.- Pancreatic Cancer.- Hepatobiliary Cancer.- Colorectal Cancer.- Anal Cancer.- Renal Cell Carcinoma.- Bladder Cancer.- Prostate Cancer.- Cancer of the Penis.- Testicular Cancer.- Cervical Cancer.- Endometrial Cancer.- Ovarian Cancer.- Vaginal Cancer.- Vulvar Cancer.- UrethralCancer.- Hodgkins Lymphoma.- Non-Hodgkins Lymphoma.- Cutaneous Lymphomas.- Multiple Myeloma and Plasmacytoma.- Bone Tumors.- Soft-Tissue Sarcoma.- Pediatric (Non-CNS) Tumors.- Palliation and Benign Conditions.- Clinical Radiobiology and Physics.